Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2B type 2-F (H2BC18) is a core component of the nucleosome, which is the basic repeating unit of chromatin structure in eukaryotic cells[2][3][6][7]. The nucleosome wraps and compacts approximately 146 base pairs of DNA around an octamer of four core histones (H2A, H2B, H3, and H4)[7]. This histone variant is encoded by the HIST2H2BF gene, found in a gene cluster on chromosome 1, and is expressed in a replication-dependent manner[3][6]. Histones, including this protein, play central roles in regulating DNA accessibility for processes such as transcription, replication, and repair, thus maintaining chromosomal stability[7]. There are no current drugs, direct therapeutic targeting, or notable biomarkers specifically associated with HIST2H2BF, and there is no evidence for clinical safety concerns or use as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2B type 2-F (H2BC18).